Ionis To Present At 43Rd Annual J.P. Morgan Healthcare Conference
(MENAFN- PR Newswire)
CARLSBAD, Calif., Jan. 8, 2025 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS ) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 43rd Annual J.P. Morgan Healthcare conference at 10:30 a.m. PT on Wednesday, January 15, 2025.
A live webcast of the presentation can be accessed on the Investors & media section of the Ionis website at . A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis and follow us on X (Twitter) and LinkedIn .
Ionis Investor Contact: D. Wade Walke, Ph.D., [email protected] – 760-603-2331
Ionis Media Contact: Hayley Soffer, [email protected] – 760-603-4679
SOURCE Ionis Pharmaceuticals, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN08012025003732001241ID1109069937
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.